Free Trial
→ The Robotics Revolution has arrived … and one $7 stock could take off as a result. (From Weiss Ratings) (Ad)
NASDAQ:ACON

Aclarion 5/15/2025 Earnings Report

Aclarion logo
$6.94 +0.04 (+0.58%)
Closing price 05/16/2025 04:00 PM Eastern
Extended Trading
$6.80 -0.14 (-2.02%)
As of 05/16/2025 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Earnings HistoryForecast

Aclarion EPS Results

Actual EPS
-$9.32
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Aclarion Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Aclarion Announcement Details

Quarter
Date
5/15/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Aclarion's next earnings date is estimated for Wednesday, May 21, 2025, based on past reporting schedules.

Conference Call Resources

Aclarion Earnings Headlines

Aclarion Inc Ordinary Shares
May 15 at 7:09 PM | morningstar.com
Aclarion Announces Texas Back Institute as New CLARITY Trial Site
May 12, 2025 | globenewswire.com
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Revolution we predicted has arrived." In fact, I believe these robots could impact 65 million Americans lives — by August of this year.
May 17, 2025 | Weiss Ratings (Ad)
Aclarion Welcomes Advocate Health as CLARITY Trial Site
May 5, 2025 | globenewswire.com
Aclarion Announces Commercial Agreement with Spine Institute of Louisiana
April 29, 2025 | globenewswire.com
Aclarion files $150M mixed securities shelf
April 26, 2025 | markets.businessinsider.com
See More Aclarion Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aclarion? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aclarion and other key companies, straight to your email.

About Aclarion

Aclarion (NASDAQ:ACON), a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

View Aclarion Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles